Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 05, 2024

Outcomes of Radium-223 Therapy in Women With HR+ Bone-Metastatic Breast Cancer Receiving Endocrine Therapy

Breast Cancer Research and Treatment


Additional Info

Breast Cancer Research and Treatment
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Breast Cancer Res Treat 2023 Dec 20;[EPub Ahead of Print], HS Rugo, CH Van Poznak, P Neven, I Danielewicz, SC Lee, M Campone, JYK Chik, E Vega Alonso, B Naume, E Brain, JM Siegel, R Li, D Uema, VJ Wagner, RE Coleman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading